From June 24, 2022 to June 30, 2022, the company has repurchased 1,334,000 shares, representing 0.34% for HKD 2.09 million. With this, the company has completed the repurchase of 1,334,000 shares, representing 0.34% for HKD 2.09 million under the buyback announced on June 24, 2022.
Lansen Pharmaceutical Holdings Limited
Equities
503
KYG5380M1033
Pharmaceuticals
1st Jan change | Capi. | |
---|---|---|
+32.95% | 700B | |
+26.51% | 569B | |
-4.97% | 358B | |
+18.83% | 330B | |
+3.54% | 287B | |
+15.70% | 236B | |
+6.68% | 202B | |
-9.08% | 197B | |
+6.70% | 161B |